These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16186739)

  • 1. Insulin resistance in HIV-infected men and women in the nutrition for healthy living cohort.
    Jones CY; Wilson IB; Greenberg AS; Shevitz A; Knox TA; Gorbach SL; Spiegelman D; Jacobson DL; Wanke C
    J Acquir Immune Defic Syndr; 2005 Oct; 40(2):202-11. PubMed ID: 16186739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort.
    Jones CY; Tang AM; Forrester JE; Huang J; Hendricks KM; Knox TA; Spiegelman D; Semba RD; Woods MN
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):475-82. PubMed ID: 17019373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.
    Brown TT; Li X; Cole SR; Kingsley LA; Palella FJ; Riddler SA; Chmiel JS; Visscher BR; Margolick JB; Dobs AS
    AIDS; 2005 Sep; 19(13):1375-83. PubMed ID: 16103768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy.
    Duong M; Petit JM; Piroth L; Grappin M; Buisson M; Chavanet P; Hillon P; Portier H
    J Acquir Immune Defic Syndr; 2001 Jul; 27(3):245-50. PubMed ID: 11464143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of insulin resistance among patients attending the HIV clinic in a Nigerian tertiary hospital.
    Dada AO; Oshodi TT; Ajie IO; Onyenekwu CP
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S607-S610. PubMed ID: 28462827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey).
    Jacobson DL; Tang AM; Spiegelman D; Thomas AM; Skinner S; Gorbach SL; Wanke C
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):458-66. PubMed ID: 16980905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study.
    Patroni A; Torti C; Tomasoni L; Quiros Roldan E; Bertelli D; Puoti M; Cadeo GP; Sleiman I; Tinelli C; Carosi G; Castelli F
    HIV Clin Trials; 2002; 3(6):451-61. PubMed ID: 12501128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women.
    Justman JE; Hoover DR; Shi Q; Tan T; Anastos K; Tien PC; Cole SR; Hyman C; Karim R; Weber K; Grinspoon S
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):312-9. PubMed ID: 18197125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.
    Mondy K; Overton ET; Grubb J; Tong S; Seyfried W; Powderly W; Yarasheski K
    Clin Infect Dis; 2007 Mar; 44(5):726-34. PubMed ID: 17278068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Lee HC; Kim JM
    Metabolism; 2009 Nov; 58(11):1523-9. PubMed ID: 19501863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition issues in the HIV-infected injection drug user: findings from the nutrition for healthy living cohort.
    Hendricks KM; Erzen HD; Wanke CA; Tang AM
    J Am Coll Nutr; 2010 Apr; 29(2):136-43. PubMed ID: 20679149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand.
    Lee B; Aurpibul L; Sirisanthana V; Mangklabruks A; Sirisanthana T; Puthanakit T
    HIV Med; 2009 Feb; 10(2):72-8. PubMed ID: 19018877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults.
    Blázquez D; Ramos-Amador JT; Saínz T; Mellado MJ; García-Ascaso M; De José MI; Rojo P; Navarro ML; Muñoz-Fernández MÁ; Saavedra J; Roa MA; Jiménez S; Beceiro J; Prieto L; Hortelano MG; González-Tomé MI
    BMC Infect Dis; 2015 Mar; 15():119. PubMed ID: 25880777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy.
    Shlay JC; Bartsch G; Peng G; Wang J; Grunfeld C; Gibert CL; Visnegarwala F; Raghavan SS; Xiang Y; Farrough M; Perry HE; Kotler D; El-Sadr WM
    J Acquir Immune Defic Syndr; 2007 Apr; 44(5):506-17. PubMed ID: 17325603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
    Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.